Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00275184Phase 3Unknown
Phase 3, randomised trial in Small bowel disorders, Gastrointestinal Bleeding (GIB) and refractory anemia (RA) comparing Citramag + Senna with Metoclopramide (2 arms). Primary endpoints: Quality of capsule endoscopic images, Stomach and small bowel transit times and 1 more. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00275184.